Natrol, LLC is recalling one lot (totaling 12,740 units) of Natrol Melatonin 3 mg, 60-count tablets because the bottles may actually contain ALA (Alpha Lipoic Acid) 300 mg capsules. The affected product is packaged in a white bottle with a purple flip-top cap and was distributed across 35 states and several international locations. Consumers who purchased this specific lot should stop using the product immediately as it contains an ingredient other than what is listed on the label.
The product is mislabeled and contains Alpha Lipoic Acid (ALA) instead of Melatonin, which can lead to consumers taking an unintended substance or dosage. This poses a health risk to individuals who may have sensitivities to ALA or who are relying on the specific effects of Melatonin.
Product refund or pharmacist consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.